Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma

References

• Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301.
   PubMed Web of Science ®Google Scholar
• Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015;24:379–396.
   PubMed Web of Science ®Google Scholar
• Agrawal N, Frederick MJ, Pickering CR, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333(6046):1154–1157.
   PubMed Web of Science ®Google Scholar
• Almeida LO, Abrahao AC, Rosselli-Murai LK, et al. NFkappaB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS Open Bio. 2014;4(1):96–104.
   PubMedGoogle Scholar
• Paluszczak J, Wisniewska D, Kostrzewska-Poczekaj M, et al. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas. Clin Oral Investig. 2017;21:1777–1788.
   PubMed Web of Science ®Google Scholar
• Worsham MJ, Chen KM, Meduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:668–677.
   PubMedGoogle Scholar
• Dong SM, Sun DI, Benoit NE, et al. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res. 2003;9(10 Pt 1):3635–3640.
   PubMed Web of Science ®Google Scholar
• Li R, Ochs MF, Ahn SM, et al. Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma. PloS One. 2014;9(3):e91263.
   PubMed Web of Science ®Google Scholar
• Guo T, Sakai A, Afsari B, et al. A novel functional splice variant of AKT3 defined by analysis of alternative splice expression in HPV-Positive oropharyngeal cancers. Cancer Res. 2017;77(19):5248–5258.
   PubMed Web of Science ®Google Scholar
• Kelley DZ, Flam EL, Izumchenko E, et al. Integrated analysis of whole-genome ChIP-Seq and RNA-Seq data of primary head and neck tumor samples associates HPV integration sites with open chromatin marks. Cancer Res. 2017;77(23):6538–6550.
   PubMed Web of Science ®Google Scholar
• Degli Esposti D, Sklias A, Lima SC, et al. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas. Genome Med. 2017;9:33.
   PubMed Web of Science ®Google Scholar
• Anayannis NV, Schlecht NF, Belbin TJ. Epigenetic mechanisms of human papillomavirus-associated head and neck cancer. Arch Pathol Lab Med. 2015;139(11):1373–1378.
   PubMed Web of Science ®Google Scholar
• Fertig EJ, Markovic A, Danilova LV, et al. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis. PLoS One. 2013;8(11):e78127.
   PubMed Web of Science ®Google Scholar
• Chen J, Weiss WA. Alternative splicing in cancer: implications for biology and therapy. Oncogene. 2015;34(1):1–14.
   PubMed Web of Science ®Google Scholar
• Kelley DZ, Flam EL, Guo T, et al. Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma. Transl Res. 2018;202:109–119.
   PubMed Web of Science ®Google Scholar
• Maunakea AK, Chepelev I, Cui K, et al. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res. 2013;23(11):1256–1269.
   PubMed Web of Science ®Google Scholar
• Narayanan SP, Singh S, Shukla S. A saga of cancer epigenetics: linking epigenetics to alternative splicing. Biochem J. 2017;474(6):885–896.
   PubMedGoogle Scholar
• Hoivik EA, Witsoe SL, Bergheim IR, et al. DNA methylation of alternative promoters directs tissue specific expression of Epac2 isoforms. PLoS One. 2013;8(7):e67925.
   PubMed Web of Science ®Google Scholar
• Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010;466(7303):253–257.
   PubMed Web of Science ®Google Scholar
• Sims RJ 3rd, Millhouse S, Chen CF, et al. Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell. 2007;28(4):665–676.
   PubMed Web of Science ®Google Scholar
• Gunderson FQ, Johnson TL, Madhani HD. Acetylation by the transcriptional coactivator Gcn5 plays a novel role in co-transcriptional spliceosome assembly. PLoS Genet. 2009;5:e1000682.
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature. 2009;459(7243):108–112.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–319.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–947.
   PubMed Web of Science ®Google Scholar
• Sengupta D, Kannan A, Kern M, et al. Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma. Epigenetics. 2015;10(6):460–466.
   PubMed Web of Science ®Google Scholar
• Li M, Bian Z, Yao S, et al. Up-regulated expression of SNHG6 predicts poor prognosis in colorectal cancer. Pathol Res Pract. 2018;214(5):784–789.
   PubMed Web of Science ®Google Scholar
• Yan K, Tian J, Shi W, et al. LncRNA SNHG6 is Associated with poor prognosis of gastric cancer and promotes cell proliferation and EMT through epigenetically silencing p27 and sponging miR-101-3p. Cell Physiol Biochem. 2017;42(3):999–1012.
   PubMed Web of Science ®Google Scholar
• Kwon RJ, Kim YH, Jeong DC, et al. Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma. PLoS One. 2017;12(2):e0171036.
   PubMed Web of Science ®Google Scholar
• Liu C, Guo T, Saki A, et al. A novel splice variant of LOXL2 promotes progression of HPV negative head and neck squamous cell carcinoma. Cancer. 2020;126(4):737–748.
   Google Scholar
• Parfenov M, Pedamallu CS, Gehlenborg N, Cancer Genome Atlas N. et al. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci U S A. 2014;111(43):15544–15549.
   PubMed Web of Science ®Google Scholar
• Rusan M, Li YY, Hammerman PS. Genomic landscape of human papillomavirus-associated cancers. Clin Cancer Res. 2015;21(9):2009–2019.
   PubMed Web of Science ®Google Scholar
• Corces MR, Granja JM, Shams S, et al. The chromatin accessibility landscape of primary human cancers. Science. 2018;362 (6413).
   Web of Science ®Google Scholar
• Warburton A, Redmond CJ, Dooley KE, et al. HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression. PLoS Genet. 2018;14(1):e1007179.
   PubMed Web of Science ®Google Scholar
• Allo M, Schor IE, Munoz MJ, et al. Chromatin and alternative splicing. Cold Spring Harb Symp Quant Biol. 2010;75:103–111.
   PubMedGoogle Scholar
• Pacini C, Koziol MJ. Bioinformatics challenges and perspectives when studying the effect of epigenetic modifications on alternative splicing. Philos Trans R Soc Lond B Biol Sci. 2018;373 (1748).
   Web of Science ®Google Scholar
• Hussong M, Kaehler C, Kerick M, et al. The bromodomain protein BRD4 regulates splicing during heat shock. Nucleic Acids Res. 2017;45:382–394.
   PubMed Web of Science ®Google Scholar
• Enomoto K, Zhu X, Park S, et al. Targeting MYC as a therapeutic intervention for anaplastic thyroid cancer. J Clin Endocrinol Metab. 2017;102(7):2268–2280.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153(2):320–334.
   PubMed Web of Science ®Google Scholar
• Issa JP, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res. 2009;15(12):3938–3946.
   PubMed Web of Science ®Google Scholar
• Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol. 2009;27(32):5459–5468.
   PubMed Web of Science ®Google Scholar
• He L, Gao L, Shay C, et al. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis. J Exp Clin Cancer Res. 2019;38(1):84.
   PubMedGoogle Scholar
• Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576–582. .
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Cheng H, Wirth P, et al. Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma. PloS One. 2010;5(9):e12702.
   PubMed Web of Science ®Google Scholar
• Guo T, Gaykalova DA, Considine M, et al. Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma. Int J Cancer J Inter Du Cancer. 2016;139(2):373–382.
   PubMed Web of Science ®Google Scholar
• Wang K, Singh D, Zeng Z, et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res. 2010;38(18):e178.
   PubMed Web of Science ®Google Scholar
• Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12(1):323.
   PubMed Web of Science ®Google Scholar
• Feng J, Liu T, Qin B, et al. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7(9):1728–1740.
   PubMed Web of Science ®Google Scholar
• Favorov A, Mularoni L, Cope LM, et al. Exploring massive, genome scale datasets with the GenometriCorr package. PLoS Comput Biol. 2012;8(5):e1002529.
   PubMed Web of Science ®Google Scholar
• Ochs MF, Farrar JE, Considine M, et al. Outlier analysis and top scoring pair for integrated data analysis and biomarker discovery. IEEE/ACM Trans Comput Biol Bioinform. 2014;11(3):520–532.
   PubMed Web of Science ®Google Scholar
• Mann HB, Whitney DR. On a test of whether one of 2 random variables is stochastically larger than the other. Ann Math Stat. 1947;18(1):50–60. .
   Google Scholar